000			02044 a2200577 4500
005			20250517082158.0
264		0	_c20170621
008			201706s 0 0 eng d
022			_a1873-7064
024	7		_a10.1016/j.neuropharm.2016.02.015 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Teng
245	0	0	_aNaturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin. _h[electronic resource]
260			_bNeuropharmacology _c06 2016
300			_a561-576 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAlzheimer Disease _xdrug therapy
650	0	4	_aAmyloid beta-Peptides _ximmunology
650	0	4	_aAnimals
650	0	4	_aAutoantibodies _xisolation & purification
650	0	4	_aBrain _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aChromatography, Affinity
650	0	4	_aCytokines _xmetabolism
650	0	4	_aDisease Models, Animal
650	0	4	_aGliosis _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImmunoglobulins, Intravenous _xtherapeutic use
650	0	4	_aImmunotherapy
650	0	4	_aMemory _xdrug effects
650	0	4	_aMice, Transgenic
650	0	4	_aNeuroimmunomodulation
650	0	4	_aNeuroprotective Agents _xisolation & purification
650	0	4	_aNootropic Agents _xisolation & purification
650	0	4	_aPeptide Fragments _ximmunology
650	0	4	_aProtein Multimerization _xdrug effects
650	0	4	_aSynaptophysin _xmetabolism
700	1		_aXie, Xi-Xiu
700	1		_aJi, Mei
700	1		_aWang, Shao-Wei
700	1		_aZha, Jun
700	1		_aZhou, Wei-Wei
700	1		_aYu, Xiao-Lin
700	1		_aWei, Chen
700	1		_aMa, Shan
700	1		_aXi, Zhi-Ying
700	1		_aPang, Guang-Li
700	1		_aLiu, Rui-Tian
773	0		_tNeuropharmacology _gvol. 105 _gp. 561-576
856	4	0	_uhttps://doi.org/10.1016/j.neuropharm.2016.02.015 _zAvailable from publisher's website
999			_c25762739 _d25762739